全球肾脏/肾功能测试市场 – 行业趋势和 2030 年预测

肾脏/肾功能测试市场分析和规模

根据美国疾病控制与预防中心的报告，预计美国有超过 3700 万人患有 CKD，而全球有超过 5 亿人患有 CKD。此外，生活方式疾病和肾脏损伤是 CKD 的主要风险因素。此外，数字尿液分析的普及表明对肾脏或肾脏疾病家庭诊断的需求不断增加，从而推动了市场增长。

Data Bridge Market Research 分析了 2023-2030 年预测期内肾脏/肾功能测试市场的增长率。在上述预测期内，肾脏/肾功能测试市场的预期复合年增长率趋于 6.20% 左右。2022 年市场价值为 8.747 亿美元，到 2030 年将增长至 14.1531 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

肾脏/肾功能测试市场范围和细分

市场定义

The kidney/renal function tests are used to diagnose any defect in the functions of the kidney. The common symptoms of these diseases are difficulty in urination due to increased body fluids, blood in urine, swelling in hands or feet, and swollen face. Kidney or Renal diseases may develop over the years, leading to end-stage kidney (or renal) disease (ESRD). It has become a massive public health issue. For the correct identification of these diseases, they are used widely.

Global Kidney/Renal Function Test Market Dynamics

Drivers

• Increased Prevalence of Kidney Diseases

The growing incidence of chronic kidney disease worldwide is majorly responsible for enhancing the market's growth. As per the National Kidney Foundation records, approximately 10% of the global population is affected by chronic kidney disease (CKD). According to WHO facts 2019, around 1.13 billion people globally have hypertension. In 2014–2016, diabetes and hypertension were responsible for about 75% of kidney failure. This increasing prevalence demands higher demand for tests for early disease detection, leading to market growth. Thus, it boosts the market growth.

• Increasing Technological Advancements by Market Players

The increased adoption of digital urinalysis specifies the increasing demand for home diagnostics, enhancing market growth. For instance, Healthy.io, a start-up in digital health headquartered in Israel, developed an FDA-cleared at-home smartphone urinalysis test to assist people in opting for kidney tests for proteins. Early detection helps to prevent complications from kidney diseases. Furthermore, the company's urinalysis test, called Dip.io, uses disposable cups and strips in combination with a smartphone camera to interpret and read the results. Thus, this factor boosts market growth.  

Opportunities

• Growing Demand for Hospitals

The wide presence of many hospitals in the U.S. and a well-developed healthcare infrastructure are other major factors leading to market growth. For instance, according to the American Hospital Association, there were about 208 federal government hospitals, 6,090 community hospitals, and 625 non-federal psychiatric hospitals in the U.S. Also, a major increase in hospital admissions for acute kidney disease is enhancing the demand for dialysis and transplant, boosting the market growth.

• Rising Strategic Agreements by Organizations

The top manufacturers in the region are primarily focused on developing innovative products. For instance, Abbott HealthTab, Inc. signed a non-assignable pilot supplier distribution agreement with Abbott for i-STAT Alinity, a handheld blood chemistry analyzer, in 2021. The agreement allows HealthTab to deliver Abbott's POC i-STAT Alinity and its associated tests for creatinine in Canadian drug stores to help patients receive necessary information about their kidney functions. Thus, this factor boosts market growth.

Restraints/Challenges

• Side Effects of Kidney/Renal Disease Drugs

The side effects associated with these renal drugs could decrease the growth of the global market over a forecast period. Effects such as loss of appetite, fever, and rashes can hamper the market growth. Other rare, more severe side effects involve decreased blood cell numbers and liver and kidney problems observed by changes in the blood tests. Thus, these factors lead to market hindrances.

This global kidney/renal function test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global kidney/renal function test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Kidney/ Renal Function Test Market Scope

The global kidney/renal function test market is segmented on the basis of product type, test type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Dipsticks
• Reagents
• Disposables

Test Type

• Urine Tests
• Blood Tests

End User

• Hospitals, Diagnostic Laboratories
• Research Laboratories and Institutes
• Others

Kidney/ Renal Function Test Market Regional Analysis/Insights

The kidney/renal function test market is analyzed and market size insights and trends are provided by product type, test type and end user as referenced above.

The major countries covered in the kidney/renal function test market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated the market growth for the kidney/renal function test market throughout the forecasted period to the huge presence of supportive government initiatives and the persistent implementation by healthcare organizations within the region.

由于政府和制药组织不断提高认识，以及仿制药制造商的广泛存在，亚太地区市场预计将出现高增长。此外，市场参与者对研发的投资迅速增加也推动了市场增长。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球肾脏/肾功能测试市场份额分析

全球肾脏/肾功能测试市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球肾脏/肾功能测试市场的关注有关

肾脏/肾功能测试市场的主要参与者包括：

• 辉瑞公司 (美国)
• 阿斯利康（英国）、
• 百时美施贵宝公司 (美国)
• F. Hoffmann-La Roche Ltd（瑞士）
• 雅培（美国）
• 丹纳赫（美国）
• 生物梅里埃（法国）
• 西门子医疗私人有限公司（德国）
• BD（美国）
• Bio-Rad Laboratories, Inc.（美国）
• Sysmex 公司 (日本)
• Nova Biomedical（美国）
• Trinity Biotech（爱尔兰）
• Alfa Scientific Designs, Inc（美国）
• IDEXX（美国）
• 贝克曼库尔特公司（美国）

SKU-27149